Thermal ablation vs surgical resection for ultrasound-detected T2N0M0 papillary thyroid carcinoma
The Oncologist · 04.06.2025 · 30 (6)
DOI: 10.1093/oncolo/oyaf170 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Oncologist, online erschienen am 30.06.2025. Verfasst von Yu-Tong Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing…. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Thyroid Neoplasms, Thyroidectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Research Ward Project, National High Level Hospital Clinical Research Funding, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Thermal ablation (TA) has demonstrated promising efficacy and safety in treating papillary thyroid carcinoma (PTC). However, comparative analyses between TA and surgical resection (SR) for treating T2N0M0 PTC remain scarce.
Purpose
To compare the efficacy and safety of TA and SR in treating preoperatively US-detected T2N0M0 PTC. Materials and Methods In this retrospective study, 252 patients with preoperative ultrasound (US)-detected T2N0M0 PTC treated by TA or SR between January 2016 and May 2024 were included. Comparative study based on propensity score matching (PSM) between the TA and SR groups was conducted.
Results
After PSM, 63 patients (median age: 40 years [IQR 34-53], 49 females) in the TA group and 126 patients (median age: 41 years [IQR 32-52.5], 102 females) in the SR group were followed for a median of 35 months (IQR 18-62) and 46 months (IQR 29-60), respectively (P = .093). There was no evidence of differences in disease progression between the TA and SR groups (11.1% vs 7.9%; P = .59) or progression-free survival rates between the TA and SR groups (86.4% vs 89.6%, P = .37). Compared with SR, TA resulted in less blood loss, a shorter incision length, and shorter procedure and hospitalization times (all, P < .001). Although there was a relatively higher incidence of hoarseness in the TA group, no significant difference was observed between the TA and SR groups (12.7% vs 8.7%, P = .444) or between the TA and lobectomy (ie, hemithyroidectomy and subtotal thyroidectomy) groups (12.7% vs 5.9%, P = .340).
Conclusions
There were no significant differences in disease progression and hoarseness between TA and SR for US-detected T2N0M0 PTC. Thermal ablation is an effective and safe treatment option for US-detected T2N0M0 PTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100029, China.
- Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
ORCID-Profile: Yu-Tong Liu, Ming-An Yu
Förderung
- Beijing Research Ward Project
- National High Level Hospital Clinical Research Funding
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y. T., Wei, Y., Zhao, Z. L., Wu, J., Cao, S. L., Yu, N., Li, Y., Peng, L. L., & Yu, M. A. (2025). Thermal ablation vs surgical resection for ultrasound-detected T2N0M0 papillary thyroid carcinoma. The Oncologist, 30(6). https://doi.org/10.1093/oncolo/oyaf170
Vancouver
Liu YT, Wei Y, Zhao ZL, Wu J, Cao SL, Yu N, et al. Thermal ablation vs surgical resection for ultrasound-detected T2N0M0 papillary thyroid carcinoma. The Oncologist. 2025;30(6). doi:10.1093/oncolo/oyaf170
BibTeX
@article{Liu2025,
author = {Liu, Yu-Tong and Wei, Ying and Zhao, Zhen-Long and Wu, Jie and Cao, Shi-Liang and Yu, Na and Li, Yan and Peng, Li-Li and Yu, Ming-An},
title = {Thermal ablation vs surgical resection for ultrasound-detected T2N0M0 papillary thyroid carcinoma},
journal = {The Oncologist},
year = {2025},
volume = {30},
number = {6},
doi = {10.1093/oncolo/oyaf170}
}
EUVIMED